The natural history of idiopathic dilated cardiomyopathy.
about
Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmAnticoagulation versus placebo for heart failure in sinus rhythmAnticoagulation versus placebo for heart failure in sinus rhythmDiagnosing and treating active myocarditisAntiplatelet agents versus control or anticoagulation for heart failure in sinus rhythmAnticoagulation for heart failure in sinus rhythmOral anticoagulants: pharmacodynamics, clinical indications and adverse effectsCase 6 / 2016 - Heart Failure in a 23-Year-Old Male with a History of Illicit Drug Use.Unusual association of ST-T abnormalities, myocarditis and cardiomyopathy with H1N1 influenza in pregnancy: two case reports and review of the literature.Referral selection bias in the Medicare hospital mortality prediction model: are centers of referral for Medicare beneficiaries necessarily centers of excellence?Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy.Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.Echocardiography in the evaluation of cardiac sources of emboli: the role of transthoracic echocardiography.Echocardiography of dilated cardiomyopathy in children.Mechanism of late stroke after myocardial infarct: the Lausanne Stroke Registry.Arterial microembolisation: an unusual presentation of dilated cardiomyopathy.Free radical activity and left ventricular function after thrombolysis for acute infarctionFamilial aggregation of idiopathic dilated cardiomyopathy: clinical features and pedigree analysis in 14 families.Familial dilated cardiomyopathy.Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group.Long-term anticoagulation. Indications and management.Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune responseLack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathyRapid histological changes in endomyocardial biopsy specimens after myocarditisA pilot study of a new chicken model of alcohol-induced cardiomyopathy.Thromboembolism in heart failure: who should be treated?Stroke: management and rehabilitation. Part III of III.Ten year clinical evaluation of Starr-Edwards 2400 and 1260 aortic valve prostheses.The course of idiopathic dilated cardiomyopathy in New Zealand.Prediction of outcome in dilated cardiomyopathyMortality in heart failure: clinical variables of prognostic valueMultistep ion channel remodeling and lethal arrhythmia precede heart failure in a mouse model of inherited dilated cardiomyopathy.Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditisHeart failure in acute ischemic strokeAntithrombotic therapy in cardiac embolism.DCM-related tropomyosin mutants E40K/E54K over-inhibit the actomyosin interaction and lead to a decrease in the number of cycling cross-bridges.Racial differences in the utilization of oral anticoagulant therapy in heart failure: a study of elderly hospitalized patients.Alcoholic cardiomyopathy: is it dose-dependent?
P2860
Q24185800-7FC7ECB2-AB67-470D-916A-B71856081608Q24197822-E909B70E-680C-4C33-8042-3E0AA929D8CBQ24202686-425EA585-5E52-4CFC-B61F-24643926BAECQ27469321-DF4D651D-FCA5-4B5D-BABE-AF7D82D93A21Q28191116-5E7E7D3F-DCBD-448A-8DDB-419BE17FF8ACQ28191123-8463A154-FE1E-4AC4-B1B5-84F65D154823Q28319507-A060B69F-3D7E-483F-BA93-AB8AB14B5908Q30101003-A10ED4B5-7B97-430B-AD8A-21C19EEA8038Q30404828-B692DFD0-5E00-479A-A71E-CB9FFD6F88ADQ30447002-8AA438B3-2F1D-442B-B6D8-9A0A5EF276F4Q30457496-7A9BD056-8295-402B-AFCE-D6A08ECC69E4Q30484358-6A12F3AE-C1A6-4AF8-84EF-AEBA86A20B8CQ31111202-5BF622EF-7C35-4627-9568-1BB337FECFBFQ33559372-7F70022E-DAD6-4481-A382-9D00DE312F85Q33563914-261B5EBA-49FB-4CBB-AC3F-6B8D08527C07Q33591295-C21775CE-F1E7-40A7-BC68-884A035E63DDQ33610318-CAF6EAD9-9D10-4E1E-ADDB-D345A603E0C2Q33612219-2F183F90-C3E3-4F0D-AF9A-62C75629FD18Q33612229-A6CEE2A7-BD67-487B-819F-8F0CBC1F9AD5Q33614491-FF37341C-DE13-44C5-86B3-6E6B5B232F34Q33614496-B11C013E-BA13-482F-AB01-D91A1A2FA24DQ33617257-9737A7DC-3478-4558-BF28-1ABD3112169DQ33638740-92BB5404-1D74-45BA-ADC2-9FC442869D53Q34000213-971641E7-DA3C-4FAA-8772-1C06DA9B40FEQ34016576-08069C00-607B-4E30-8C12-5DF01420F7E4Q34074802-1807DAE0-13F0-494B-9949-F0AF81BE3CB0Q34103002-05EE4B1E-FDB5-43C2-9891-4A90DC6BC3DAQ34116128-72DFB007-6EB6-4296-A8A2-977370811530Q34118111-DC33FAC6-E010-43B0-AFD1-E430B81BFA05Q34118272-ED416A99-10FD-47D1-84AA-B712990B4FFFQ34118481-11E2AE34-F7F2-4CE5-877A-15274E0488DEQ34118615-3D4C882A-C393-4FA5-981D-7BEBCEA1925CQ34238976-70F3E1A6-657A-4FA5-8601-734EE708BC5CQ34276182-4C3AF4FC-121C-4245-9978-FD72DA1399B3Q34299695-8DC37E4D-1614-4CE7-8F19-02F1C7E64C2DQ34362887-ED79370A-171F-484B-BB40-277394C6E6E4Q34362901-D45DCC49-AD4B-4FA6-87FF-215A32181477Q34450885-E2F1D263-B792-4C35-B27E-3561D0C90F9AQ34744906-49786E74-9FA7-4EDD-BC11-638468D30FCDQ35013817-6E4FEA60-31C1-4943-ABBB-589BCA6F139F
P2860
The natural history of idiopathic dilated cardiomyopathy.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
The natural history of idiopathic dilated cardiomyopathy.
@en
type
label
The natural history of idiopathic dilated cardiomyopathy.
@en
prefLabel
The natural history of idiopathic dilated cardiomyopathy.
@en
P2093
P1476
The natural history of idiopathic dilated cardiomyopathy.
@en
P2093
E R Giuliani
R O Brandenburg
P304
P356
10.1016/0002-9149(81)90534-8
P407
P577
1981-03-01T00:00:00Z